Selling, page-109

That is wrong. The registration study is Phase IIb that is what is meant by accelerated approval. I can't believe you haven't got this they went over it so many times. Look it up. Edison have it right they need 11-15M to finish phase II but it is an expanded Phase II which can lead to registration FDA has done this with other PI3K so can be done this way especially with ODD. This is why they refer to it as the registration study which is usually a Phase III.

As for the costs discovery is fickle and no doubt there is a huge difference in development costs. This should be cheap cause Genetech didn't want it but only if it works and only if they can make a profit.

You will have to accept that I don't agree that paying so much for Glioblast was in the best interests of shareholders. This is my opinion. Look at the reality of it.

I will post at my leisure I don't make deals I can't keep like putting people on ignore and off again or restraint of posting.

KEEP IT BRIEF guys.